JPRN-UMIN000009552已完成未知
The tolerability study of oligomeric formula for early enteral nutrition in critically ill patients - The tolerability study of oligomeric formula
Department of Respiratory Medicine, Hamamatsu Medical Center0 个研究点目标入组 24 人开始时间: 2012年12月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Severe intolerability for enteral nutrition or formula. 2. Patients having problem for administration of enteral nutrition. 3. Patients having problem to evaluate the intolerability due to complicated diseases during the study. 4. Patients judged as inadequate case by physician.
研究者
相似试验
已完成
不适用
Evaluation of effects of formulas containing oligosaccharides on the fecal microflora of young childreot applicableJPRN-UMIN000029289SOUKEN Co., Ltd.60
已完成
不适用
The investigation of the tolerability and the cost, due to the drug change to novel oral anticoagurants (rivaroxaban) from warfarin in patients with nonvalvular atrial fibrillation in the perioperative periodonvalvular Atrial FibrillationJPRN-UMIN000011103Osaka General Medical Center50
进行中（未招募）
1 期
Cysteamine in Cystic FibrosisCystic FibrosisEUCTR2014-000284-40-GBniversity of Aberdeen12
进行中（未招募）
不适用
An Evaluation of the Tolerability and Feasibility of combining 5-Amino-Levulinic Acid (5-ALA) with Carmustine Wafers (Gliadel) in the Surgical Management of Primary Glioblastoma (GALA-5 Trial) - Feasibility of 5-ALA and Carmustine wafers for Glioblastoma (GALA-5)Primary glioblastomaMedDRA version: 14.0Level: PTClassification code 10018336Term: GlioblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-022496-66-GBJoint UCLH and UCL Biomedical Research Unit
进行中（未招募）
1 期
An open-label investigation into the tolerability and pharmacokinetic / pharmacodynamic effects of sufugolix (TAK-013), at a dosage of 100mg twice-daily, during six months treatment of pre-menopausal women with endometriosis.symptomatic endometriosisMedDRA version: 7Level: LLTClassification code 10014778EUCTR2004-003829-28-GBTakeda Europe R&D Centre Ltd